These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 1872925)

  • 1. A controlled study on the effects of n-3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients.
    Annuzzi G; Rivellese A; Capaldo B; Di Marino L; Iovine C; Marotta G; Riccardi G
    Atherosclerosis; 1991 Mar; 87(1):65-73. PubMed ID: 1872925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.
    Rivellese AA; Maffettone A; Iovine C; Di Marino L; Annuzzi G; Mancini M; Riccardi G
    Diabetes Care; 1996 Nov; 19(11):1207-13. PubMed ID: 8908381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supplementation with n-3 fatty acids reduces triglycerides but increases PAI-1 in non-insulin-dependent diabetes mellitus.
    Boberg M; Pollare T; Siegbahn A; Vessby B
    Eur J Clin Invest; 1992 Oct; 22(10):645-50. PubMed ID: 1459169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM.
    Borkman M; Chisholm DJ; Furler SM; Storlien LH; Kraegen EW; Simons LA; Chesterman CN
    Diabetes; 1989 Oct; 38(10):1314-9. PubMed ID: 2676659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial.
    Toft I; Bønaa KH; Ingebretsen OC; Nordøy A; Jenssen T
    Ann Intern Med; 1995 Dec; 123(12):911-8. PubMed ID: 7486485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the effects of dietary n-3 fatty acids (Maxepa) on plasma lipids and lipoproteins in patients with hyperlipidaemia.
    Simons LA; Hickie JB; Balasubramaniam S
    Atherosclerosis; 1985 Jan; 54(1):75-88. PubMed ID: 3888229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes.
    McManus RM; Jumpson J; Finegood DT; Clandinin MT; Ryan EA
    Diabetes Care; 1996 May; 19(5):463-7. PubMed ID: 8732710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fish oil supplements in NIDDM subjects. Controlled study.
    Hendra TJ; Britton ME; Roper DR; Wagaine-Twabwe D; Jeremy JY; Dandona P; Haines AP; Yudkin JS
    Diabetes Care; 1990 Aug; 13(8):821-9. PubMed ID: 2209315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial.
    Qin Y; Zhou Y; Chen SH; Zhao XL; Ran L; Zeng XL; Wu Y; Chen JL; Kang C; Shu FR; Zhang QY; Mi MT
    PLoS One; 2015; 10(7):e0133496. PubMed ID: 26226139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment for 6 months with fish oil-derived n-3 polyunsaturated fatty acids has neutral effects on glycemic control but improves dyslipidemia in type 2 diabetic patients with abdominal obesity: a randomized, double-blind, placebo-controlled trial.
    Wang F; Wang Y; Zhu Y; Liu X; Xia H; Yang X; Sun G
    Eur J Nutr; 2017 Oct; 56(7):2415-2422. PubMed ID: 27913872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension.
    Woodman RJ; Mori TA; Burke V; Puddey IB; Watts GF; Beilin LJ
    Am J Clin Nutr; 2002 Nov; 76(5):1007-15. PubMed ID: 12399272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
    Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
    Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of omega 3 fatty acid on plasma lipids, cholesterol and lipoprotein fatty acid content in NIDDM patients.
    Goh YK; Jumpsen JA; Ryan EA; Clandinin MT
    Diabetologia; 1997 Jan; 40(1):45-52. PubMed ID: 9028717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized-controlled clinical trial investigating the effect of omega-3 fatty acids and vitamin E co-supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes.
    Taghizadeh M; Jamilian M; Mazloomi M; Sanami M; Asemi Z
    J Clin Lipidol; 2016; 10(2):386-93. PubMed ID: 27055970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of fish oil on lipoprotein subfractions and low density lipoprotein size in non-insulin-dependent diabetic patients with hypertriglyceridemia.
    Patti L; Maffettone A; Iovine C; Marino LD; Annuzzi G; Riccardi G; Rivellese AA
    Atherosclerosis; 1999 Oct; 146(2):361-7. PubMed ID: 10532692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dependent effects of docosahexaenoic acid supplementation on blood lipids in statin-treated hyperlipidaemic subjects.
    Meyer BJ; Hammervold T; Rustan AC; Howe PR
    Lipids; 2007 Mar; 42(2):109-15. PubMed ID: 17393216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic response to omega-3 fatty acid supplementation in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial.
    Soleimani A; Taghizadeh M; Bahmani F; Badroj N; Asemi Z
    Clin Nutr; 2017 Feb; 36(1):79-84. PubMed ID: 26611718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Results of a controlled study.
    Luo J; Rizkalla SW; Vidal H; Oppert JM; Colas C; Boussairi A; Guerre-Millo M; Chapuis AS; Chevalier A; Durand G; Slama G
    Diabetes Care; 1998 May; 21(5):717-24. PubMed ID: 9589230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men.
    Mori TA; Burke V; Puddey IB; Watts GF; O'Neal DN; Best JD; Beilin LJ
    Am J Clin Nutr; 2000 May; 71(5):1085-94. PubMed ID: 10799369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism.
    Ylönen SK; Salminen I; Lyssenko V; Virtanen SM; Groop L; Aro A; Saloranta C;
    Eur J Clin Nutr; 2008 Dec; 62(12):1432-9. PubMed ID: 17700648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.